ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•]Preferred Stock Warrant Agreement • April 10th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•]Common Stock Warrant Agreement • April 10th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
ELOXX PHARMACEUTICALS, INC. and [•], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [•], 20[•]Warrant Agreement • April 10th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
